Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-11-295353
Filing Date
2011-11-03
Accepted
2011-11-03 17:06:09
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d247773ds3.htm S-3 276353
2 EX-4.7 d247773dex47.htm EX-4.7 34929
3 EX-4.8 d247773dex48.htm EX-4.8 390353
4 EX-4.9 d247773dex49.htm EX-4.9 36977
5 EX-4.10 d247773dex410.htm EX-4.10 433076
6 EX-5.1 d247773dex51.htm EX-5.1 27542
7 EX-12.1 d247773dex121.htm EX-12.1 31798
8 EX-23.1 d247773dex231.htm EX-23.1 2315
  Complete submission text file 0001193125-11-295353.txt   1234401
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-177719 | Film No.: 111178466
SIC: 2835 In Vitro & In Vivo Diagnostic Substances